-+ 0.00%
-+ 0.00%
-+ 0.00%

Xinhua Pharmaceutical (000756.SZ): Nimodipine tablets passed generic drug consistency evaluation

Zhitongcaijing·10/19/2026 10:09:26
Listen to the news

Zhitong Finance App News, Xinhua Pharmaceuticals (000756.SZ) issued an announcement. Recently, the company received the “Drug Supplement Application Approval Notice” for nimodipine tablets approved and issued by the State Drug Administration. The product passed the consistent evaluation of the quality and efficacy of generic drugs.

According to reports, this drug can prevent and treat ischemic nerve damage caused by cerebrovascular spasms after aneurysm subarachnoid hemorrhage as a continuing treatment after prior use of nimodipine injection. This drug can also be used to treat senile brain dysfunction, such as: memory loss, disorientation and attention disorders, and mood swings. Before treatment, make sure these symptoms are not caused by an underlying condition requiring specific treatment.